Patents by Inventor Gabriel Gojon-Romanillos

Gabriel Gojon-Romanillos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240066001
    Abstract: The present invention relates to compositions and kits including a chemical uncoupler, such as tyrphostin 9 or precursor or a salt thereof, and compositions including a chemical uncoupler, such as tyrphostin 9 in combination with one or more therapeutic agents, for example, L-carnitine, which are useful, for example, in treating obesity, preventing weight gain, promoting weight loss/slimming, and/or treating or preventing the development of diabetes.
    Type: Application
    Filed: October 23, 2023
    Publication date: February 29, 2024
    Inventors: Gabriel GOJON-ZORRILLA, Gabriel GOJON-ROMANILLOS
  • Publication number: 20230165893
    Abstract: The present invention features treatment of viral infections, e.g., infections caused by enveloped viruses, by administering sulfur-rich compositions.
    Type: Application
    Filed: May 4, 2021
    Publication date: June 1, 2023
    Inventors: Gabriel GOJON-ROMANILLOS, Gabriel GOJON-ZORRILLA
  • Publication number: 20210186918
    Abstract: The present invention relates to compositions and kits including a chemical uncoupler, such as tyrphostin 9 or precursor or a salt thereof, and compositions including a chemical uncoupler, such as tyrphostin 9 in combination with one or more therapeutic agents, for example, L-carnitine, which are useful, for example, in treating obesity, preventing weight gain, promoting weight loss/slimming, and/or treating or preventing the development of diabetes.
    Type: Application
    Filed: November 30, 2020
    Publication date: June 24, 2021
    Inventors: Gabriel GOJON-ZORRILLA, Gabriel GOJON-ROMANILLOS
  • Patent number: 10849872
    Abstract: The present invention relates to compositions and kits including a chemical uncoupler, such as tyrphostin 9 or precursor or a salt thereof, and compositions including a chemical uncoupler, such as tyrphostin 9 in combination with one or more therapeutic agents, for example, L-carnitine, which are useful, for example, in treating obesity, preventing weight gain, promoting weight loss/slimming, and/or treating or preventing the development of diabetes.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: December 1, 2020
    Assignee: NAN Global, LLC
    Inventors: Gabriel Gojon-Zorrilla, Gabriel Gojon-Romanillos
  • Publication number: 20160000745
    Abstract: The present invention relates to compositions and kits including a chemical uncoupler, such as tyrphostin 9 or precursor or a salt thereof, and compositions including a chemical uncoupler, such as tyrphostin 9 in combination with one or more therapeutic agents, for example, L-carnitine, which are useful, for example, in treating obesity, preventing weight gain, promoting weight loss/slimming, and/or treating or preventing the development of diabetes.
    Type: Application
    Filed: July 2, 2015
    Publication date: January 7, 2016
    Inventors: Gabriel GOJON-ZORRILLA, Gabriel GOJON-ROMANILLOS
  • Publication number: 20150064286
    Abstract: The present invention features sulfur-rich compositions and preparations thereof that are safe and effective as hydrogen sulfide prodrugs of high bioavailability. The invention also includes methods of treating pathological conditions associated with oxidative stress using sulfur-rich compositions. The invention further includes sulfur-rich compositions as antidotes and medical food for preserving and promoting general health.
    Type: Application
    Filed: September 13, 2012
    Publication date: March 5, 2015
    Applicants: EMORY UNIVERSITY, NUEVAS ALTERNATIVAS NATURALES, S.A.P.I. DE C.V.
    Inventors: Gabriel Gojon-Romanillos, Gabriel Gojon-Zarrilla, David J. Lefer
  • Publication number: 20140322361
    Abstract: The present invention features sulfur-rich compositions and preparations thereof that are safe and effective as hydrogen sulfide prodrugs of high bioavailability. The invention also includes methods of treating pathological conditions associated with oxidative stress using sulfur-rich compositions. The invention further includes sulfur-rich compositions as antidotes and medical food for preserving and promoting general health.
    Type: Application
    Filed: April 16, 2014
    Publication date: October 30, 2014
    Applicant: NUEVAS ALTERNATIVAS NATURALES, S.A.P.I. DE C.V.
    Inventors: Gabriel GOJON-ROMANILLOS, Gabriel GOJON-ZORRILLA
  • Patent number: 8771755
    Abstract: The present invention features sulfur-rich compositions and preparations thereof that are safe and effective as hydrogen sulfide prodrugs of high bioavailability. The invention also includes methods of treating pathological conditions associated with oxidative stress using sulfur-rich compositions. The invention further includes sulfur-rich compositions as antidotes and medical food for preserving and promoting general health.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: July 8, 2014
    Assignee: Nuevas Alternativas Naturales, S.A.P.I. de C.V.
    Inventors: Gabriel Gojon-Romanillos, Gabriel Gojon-Zorrilla
  • Publication number: 20130064904
    Abstract: The present invention features sulfur-rich compositions and preparations thereof that are safe and effective as hydrogen sulfide prodrugs of high bioavailability. The invention also includes methods of treating pathological conditions associated with oxidative stress using sulfur-rich compositions. The invention further includes sulfur-rich compositions as antidotes and medical food for preserving and promoting general health.
    Type: Application
    Filed: September 13, 2012
    Publication date: March 14, 2013
    Applicant: Nuevas Alternativas Naturales, S.A.P.I. de C.V.
    Inventors: Gabriel Gojon-Romanillos, Gabriel Gojon-Zorrilla
  • Patent number: 8389005
    Abstract: Alterations of redox homeostasis in mammals underlie a host of symptoms, syndromes and diseases, including AIDS and cancer, which can be successfully treated by administration to a mammal of therapeutically-effective amounts of sulfide compounds and/or thiosulfate compounds and/or thionite compounds and/or thionate compounds and/or any organic, inorganic or organometallic precursors thereof. The unique compositions of this invention contain one or more “active sulfur compounds” in combination with each other or with other therapeutic agents. The invention also encompasses the varying modes of administration of the therapeutic compounds.
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: March 5, 2013
    Assignee: Nuevas Alternativas Naturales Thermafat, S.A.P.I. de C.V.
    Inventor: Gabriel Gojon-Romanillos
  • Patent number: 8361514
    Abstract: Alterations of redox homeostasis in mammals underlie a host of symptoms, syndromes and diseases, including AIDS and cancer, which can be successfully treated by administration to a mammal of therapeutically-effective amounts of sulfide compounds and/or thiosulfate compounds and/or thionite compounds and/or sulfite compounds and/or thionate compounds and/or any organic, inorganic or organometallic precursors thereof. The unique compositions of this invention contain one or more “active sulfur compounds” in combination with each other or with other therapeutic agents. The invention also encompasses the varying modes of administration of the therapeutic compounds. In particular, a novel method of combining active ingredient with wet cellulose is provided, which allows the wet cellulose to function as an enteric carrier.
    Type: Grant
    Filed: August 18, 2009
    Date of Patent: January 29, 2013
    Assignee: Nuevas Alternatives Naturales Thermafat, S.A.P.I. de C.V.
    Inventor: Gabriel Gojon-Romanillos
  • Publication number: 20090304819
    Abstract: Alterations of redox homeostasis in mammals underlie a host of symptoms, syndromes and diseases, including AIDS and cancer, which can be successfully treated by administration to a mammal of therapeutically-effective amounts of sulfide compounds and/or thiosulfate compounds and/or thionite compounds and/or sulfite compounds and/or thionate compounds and/or any organic, inorganic or organometallic precursors thereof. The unique compositions of this invention contain one or more “active sulfur compounds” in combination with each other or with other therapeutic agents. The invention also encompasses the varying modes of administration of the therapeutic compounds. In particular, a novel method of combining active ingredient with wet cellulose is provided, which allows the wet cellulose to function as an enteric carrier.
    Type: Application
    Filed: August 18, 2009
    Publication date: December 10, 2009
    Inventor: Gabriel Gojon-Romanillos
  • Publication number: 20090181081
    Abstract: Alterations of redox homeostasis in mammals underlie a host of symptoms, syndromes and diseases, including AIDS and cancer, which can be successfully treated by administration to a mammal of therapeutically-effective amounts of sulfide compounds and/or thiosulfate compounds and/or thionite compounds and/or sulfite compounds and/or thionate compounds and/or any organic, inorganic or organometallic precursors thereof. The unique compositions of this invention contain one or more “active sulfur compounds” in combination with each other or with other therapeutic agents. The invention also encompasses the varying modes of administration of the therapeutic compounds.
    Type: Application
    Filed: March 16, 2009
    Publication date: July 16, 2009
    Inventor: Gabriel Gojon-Romanillos
  • Publication number: 20030235571
    Abstract: Alterations of redox homeostasis in mammals underlie a host of symptoms, syndromes and diseases, including AIDS and cancer, which can be successfully treated by administration to a mammal of therapeutically-effective amounts of sulfide compounds and/or thiosulfate compounds and/or thionite compounds and/or sulfite compounds and/or thionate compounds and/or any organic, inorganic or organometallic precursors thereof. The unique compositions of this invention contain one or more “active sulfur compounds” in combination with each other or with other therapeutic agents. The invention also encompasses the varying modes of administration of the therapeutic compounds.
    Type: Application
    Filed: June 18, 2003
    Publication date: December 25, 2003
    Inventor: Gabriel Gojon-Romanillos